H5N1 avian influenza vaccine (PowderMed)

H5N1禽流感疫苗

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH5N1 avian influenza vaccine (PowderMed)

Drug Alias NameH5N1 avian influenza virus vaccineH5N1 avian influenza virus vaccine research programmepPML-7789

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza in Birds

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsInfluenza in Birds

Other Information

ATC CodeN/A